Lung Ultrasound for Heart Failure
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to examine shorter hospitalization length as well as a reduced rates of recurrent heart failure hospitalization compared to current standard of care in Acute Decompensated Heart Failure. A 1-day reduction in hospital length of stay in unblinded subjects receiving daily HF-FOCUS examinations compared to a blinded standard of care arm.
Who Is on the Research Team?
Jared Bird, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo daily lung ultrasound examinations with results either reported to or blinded from provider care teams
Follow-up
Participants are monitored for safety and effectiveness after treatment, including changes in diuresis and lung congestion
What Are the Treatments Tested in This Trial?
Interventions
- Lung Ultrasound
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Patients undergoing daily lung ultrasound but the results will be blinded to the provider care teams
Patients undergoing daily lung ultrasound with the results reported to the provider care teams on admission and each morning
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.